Chinook Therapeutics (KDNY) 10-K 2022 FY Annual report

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos.333-203508, 333-210016, 333-216373, 333-223382, 333-229915, 333-237034, 333-249351, 333-255109, 333-263649 and 333-268295), the Registration Statement on Form S-3 (No. 333-255099), and the Registration Statement on Form S-3ASR (No. 333-265168) of Chinook Therapeutics, Inc. of our report dated February 27, 2023 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Seattle, Washington

February 27, 2023

1